Related MeSH Hierarchy (8)
Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Nervous System Neoplasms » Central Nervous System Neoplasms » Brain Neoplasms » Supratentorial Neoplasms » Hypothalamic Neoplasms » Pituitary Neoplasms
Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Endocrine Gland Neoplasms » Pituitary Neoplasms
Diseases [C] » Nervous System Diseases [C10] » Central Nervous System Diseases » Brain Diseases » Brain Neoplasms » Supratentorial Neoplasms » Hypothalamic Neoplasms » Pituitary Neoplasms
Diseases [C] » Nervous System Diseases [C10] » Central Nervous System Diseases » Brain Diseases » Hypothalamic Diseases » Hypothalamic Neoplasms » Pituitary Neoplasms
Diseases [C] » Nervous System Diseases [C10] » Central Nervous System Diseases » Brain Diseases » Hypothalamic Diseases » Pituitary Diseases » Pituitary Neoplasms
Diseases [C] » Nervous System Diseases [C10] » Nervous System Neoplasms » Central Nervous System Neoplasms » Brain Neoplasms » Supratentorial Neoplasms » Hypothalamic Neoplasms » Pituitary Neoplasms
Diseases [C] » Endocrine System Diseases [C19] » Endocrine Gland Neoplasms » Pituitary Neoplasms
Diseases [C] » Endocrine System Diseases [C19] » Pituitary Diseases » Pituitary Neoplasms
Description
Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA. MeSH
Hierarchy View
Subtype Terms (3)
ACTH-Secreting Pituitary Adenoma
1 approved drug
Growth Hormone-Secreting Pituitary Adenoma
1 approved drug
Prolactinoma
8 drugs (7 approved, 1 experimental)
Phase 4 Indicated Drugs (16)
Phase 1 Indicated Drugs (5)
Other Experimental Indicated Drugs (7)
Organization Involved with Phase 4 Indications (10)
Organization Involved with Phase 3 Indications (6)
Organization Involved with Phase 2 Indications (13)
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (12)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
